Alzheimer Disease, Early Onset
|
|
0.010 |
GeneticVariation
|
BEFREE |
The MAPT R406W mutation is associated with EOAD-like symptoms and parkinsonism without FTD, as well as distinct cognitive courses.
|
23727082 |
2014 |
Alzheimer's Disease
|
|
0.080 |
GeneticVariation
|
BEFREE |
Carbazole and 2-arylquinoline binding was only observed in cases with Alzheimer's disease and one case with frontotemporal dementia and parkinsonism linked to chromosome 17 exhibiting a R406W MAPT mutation.
|
29716656 |
2018 |
Alzheimer's Disease
|
|
0.080 |
GeneticVariation
|
BEFREE |
Conditional expression systems for 4-repeat wild-type (WT) tau or the corresponding mutants V337M and R406W were established in human neuroglioma H4 cells to study the effect of tau mutations on the physicochemical properties of tau, and to develop a cellular model for the formation of filamentous tau characteristic of frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) and Alzheimer's disease.
|
12414518 |
2002 |
Alzheimer's Disease
|
|
0.080 |
GeneticVariation
|
BEFREE |
These results suggest that R406W Tg mice exhibit changes in depression-related behavior involving serotonergic neurons and provide an animal model for investigating AD with depression.
|
16182262 |
2005 |
Alzheimer's Disease
|
|
0.080 |
GeneticVariation
|
BEFREE |
Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation.
|
18284428 |
2008 |
Alzheimer's Disease
|
|
0.080 |
GeneticVariation
|
BEFREE |
Among different MAPT mutations, the R406W mutation has been reported with a phenotype resembling Alzheimer's disease.
|
26086902 |
2015 |
Alzheimer's Disease
|
|
0.080 |
GeneticVariation
|
BEFREE |
The MAPT c.1216C > T (p.Arg406Trp; R406W) mutation is a known cause of frontotemporal dementia with Parkinsonism linked to chromosome 17 tau with Alzheimer's disease-like clinical features.
|
29370822 |
2018 |
Alzheimer's Disease
|
|
0.080 |
GeneticVariation
|
BEFREE |
The R406W tau mutation is a unique missense mutation whose patients have been reported to exhibit Alzheimer's disease (AD)-like phenotypes rather than the more typical FTD phenotypes.
|
31543469 |
2019 |
Alzheimer's Disease
|
|
0.080 |
GeneticVariation
|
BEFREE |
Therefore, these mice that exhibit a phenotype mimicking R406W FTDP-17 provide an animal model for investigating the adverse properties associated with this mutation, which might potentially recapitulate some etiological events in Alzheimer's disease.
|
12368474 |
2002 |
Amnesia
|
|
0.010 |
GeneticVariation
|
BEFREE |
MAPT p.R406W carriers present clinically with progressive memory loss and neuropathologically with neuronal and glial tauopathy.
|
30546007 |
2018 |
Anxiety
|
|
0.010 |
GeneticVariation
|
BEFREE |
In contrast, the motor function and anxiety-related emotional response of R406W Tg mice were normal.
|
16182262 |
2005 |
Anxiety Disorders
|
|
0.010 |
GeneticVariation
|
BEFREE |
In contrast, the motor function and anxiety-related emotional response of R406W Tg mice were normal.
|
16182262 |
2005 |
Behavioral Symptoms
|
|
0.010 |
GeneticVariation
|
BEFREE |
R406W homozygotes had an earlier age at onset and a higher frequency of behavioral symptoms and Parkinsonism than heterozygotes.
|
29370822 |
2018 |
Cognition Disorders
|
|
0.010 |
GeneticVariation
|
BEFREE |
Our results prove that combination of the V337M and R406W mutations of tau accelerates human tau phosphorylation and induces tau pathology as well as cognitive deficits, making this model a suitable tool for basic research on tau as well as in vivo drug testing.
|
22797329 |
2013 |
Corticobasal degeneration
|
|
0.010 |
GeneticVariation
|
BEFREE |
The authors report that the R406W mutation is lacking in 25 unrelated individuals with PSP and in six unrelated individuals with another tauopathy-corticobasal degeneration.
|
9932968 |
1999 |
Dementia
|
|
0.030 |
GeneticVariation
|
BEFREE |
Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation.
|
23727082 |
2014 |
Dementia
|
|
0.030 |
GeneticVariation
|
BEFREE |
We report clinical, molecular, neuroimaging and neuropathological features of a Danish family with autosomal dominant inherited dementia, a clinical phenotype resembling Alzheimer's disease and a pathogenic mutation (R406W) in the microtubule associated protein tau (MAPT) gene.
|
18284428 |
2008 |
Dementia
|
|
0.030 |
GeneticVariation
|
BEFREE |
Dementia in one or more first-degree family members was found in 43% of patients and mutation analysis of the tau gene showed mutations in 34 patients (19 P301L, five L315R, four G272V, four R406W, one Delta K280 and one S320F), all with a positive family history for dementia (14% of the total population, 32% of patients with a positive family history).
|
12876142 |
2003 |
Depressed mood
|
|
0.010 |
GeneticVariation
|
BEFREE |
These results suggest that R406W Tg mice exhibit changes in depression-related behavior involving serotonergic neurons and provide an animal model for investigating AD with depression.
|
16182262 |
2005 |
Depressive disorder
|
|
0.010 |
GeneticVariation
|
BEFREE |
These results suggest that R406W Tg mice exhibit changes in depression-related behavior involving serotonergic neurons and provide an animal model for investigating AD with depression.
|
16182262 |
2005 |
Familial Alzheimer's disease of early onset
|
|
0.010 |
GeneticVariation
|
BEFREE |
These observations suggest that although PSEN1 mutations are the most frequent cause, the MAPT R406W mutation is an important cause of early-onset familial dementia clinically diagnosed as AD.
|
18587238 |
2008 |
Familial Dementia
|
|
0.010 |
GeneticVariation
|
BEFREE |
These observations suggest that although PSEN1 mutations are the most frequent cause, the MAPT R406W mutation is an important cause of early-onset familial dementia clinically diagnosed as AD.
|
18587238 |
2008 |
Frontotemporal dementia
|
|
0.800 |
GeneticVariation
|
BEFREE |
Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia.
|
27345791 |
2016 |
Frontotemporal dementia
|
|
0.800 |
GeneticVariation
|
BEFREE |
Carbazole and 2-arylquinoline binding was only observed in cases with Alzheimer's disease and one case with frontotemporal dementia and parkinsonism linked to chromosome 17 exhibiting a R406W MAPT mutation.
|
29716656 |
2018 |
Frontotemporal dementia
|
|
0.800 |
GeneticVariation
|
BEFREE |
Conditional expression systems for 4-repeat wild-type (WT) tau or the corresponding mutants V337M and R406W were established in human neuroglioma H4 cells to study the effect of tau mutations on the physicochemical properties of tau, and to develop a cellular model for the formation of filamentous tau characteristic of frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) and Alzheimer's disease.
|
12414518 |
2002 |